ReviewNeuroscience letters2013

Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.

Polina Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.